Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

by | Jun 2, 2025 | Stock Market

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Article Attribution | Read More at Article Source